DUBLIN, Aug. 12, 2021 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration […] Strengthened value propositions represent the latest step in SGD Pharma’s commitment to continuous improvement. SGD Pharma elevates Type I molded […] NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TERRY WHITE CHEMISTS VENLAFAXINE XR CAPSULES Contains […] A new study led by George Mason University’s College of Health and Human Services found new insights into the link […] Are our personalities and behaviors shaped more by our genes or our circumstances? While this age-old “nature vs. nurture” question […] Efforts to control health care costs in the United States often focus on the listed prescription drug prices, but a […] A new drug that inhibits neonatal seizures in rodent models could open up new avenues for the treatment of epilepsy […] New research from the University of Illinois at Chicago shows that when pharmacies close, people stop taking widely used heart […] BOSTON, Dec. 13, 2018 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization […] The gut microbiome — the world of microbes that inhabit the human intestinal tract — has captured the interest of […]Pharmaceuticals
Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia in Adults
Key Milestone in Molded Glass: SGD Pharma Elevates Type I Offering with Three Tailored Product and Service Solutions
Terry White Chemists Venlafaxine XR
New insights on overdose rates, county segregation, and socioeconomics
Parental ‘memory’ is inherited across generations
Reforming pharmacy benefit manager practices may lead to drug cost savings
New drug could help treat neonatal seizures
People with heart disease at risk when pharmacies close: Study shows link between closures, medication use
Rhythm Pharmaceuticals Announces First Patient Enrolled in Pivotal Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes
Modeling the microbiome: Physicists develop new mathematical approaches to analyze interactions between gut bacteria
Copyright © 2025